Broadway Financial (BYFC)
(Delayed Data from NSDQ)
$5.15 USD
+0.14 (2.79%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $4.96 -0.19 (-3.69%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Broadway Financial Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | NA | 37 | 28 | 19 | 18 |
Cost Of Goods | NA | 2 | 2 | 3 | 4 |
Gross Profit | NA | 35 | 26 | 16 | 14 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 26 | 29 | 14 | 12 |
Income After Depreciation & Amortization | 0 | 9 | -3 | 1 | 2 |
Non-Operating Income | NA | 0 | 0 | 0 | 0 |
Interest Expense | NA | 1 | 2 | 2 | 2 |
Pretax Income | NA | 8 | -5 | -1 | -1 |
Income Taxes | NA | 2 | -1 | 0 | 0 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | 6 | -4 | -1 | 0 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | 6 | -4 | -1 | 0 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 9 | -2 | 2 | 2 |
Depreciation & Amortization (Cash Flow) | NA | 0 | 1 | 1 | 1 |
Income After Depreciation & Amortization | 0 | 9 | -3 | 1 | 2 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | 8.81 | 7.23 | 4.01 | 3.44 |
Diluted EPS Before Non-Recurring Items | NA | 0.64 | -0.56 | -0.16 | -0.08 |
Diluted Net EPS (GAAP) | NA | 0.64 | -0.56 | -0.16 | -0.08 |
Fiscal Year end for Broadway Financial Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | 11.90 | 11.46 |
Cost Of Goods | NA | NA | NA | 1.55 | 1.30 |
Gross Profit | NA | NA | NA | 10.35 | 10.16 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 7.19 | 6.30 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 3.16 | 3.86 |
Non-Operating Income | NA | NA | NA | 0.00 | 0.00 |
Interest Expense | NA | NA | NA | 2.82 | 1.60 |
Pretax Income | NA | NA | NA | 0.34 | 2.27 |
Income Taxes | NA | NA | NA | 0.09 | 0.67 |
Minority Interest | NA | NA | NA | 0.00 | 0.02 |
Investment Gains/Losses | NA | NA | NA | 0.00 | 0.00 |
Other Income/Charges | NA | NA | NA | 0.00 | 0.00 |
Income From Cont. Operations | NA | NA | NA | 0.25 | 1.60 |
Extras & Discontinued Operations | NA | NA | NA | 0.00 | 0.00 |
Net Income (GAAP) | NA | NA | NA | 0.24 | 1.57 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | 7.57 | 9.83 |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | 0.00 | 0.16 |
Diluted Net EPS (GAAP) | NA | NA | NA | 0.03 | 0.16 |